Inhibrx Inc 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Brendan P. Eckelman | 7 | -280,000 |
Mark Lappe | 5 | -104,060 |
Jon Faiz Kayyem | 4 | -38,000 |
Viking Global Investors Lp | 2 | 1,844,960 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 0 | 0 |
最近6个月 | 0 | 0 | 0 |
最近12个月 | 511,627 | 0 | 511,627 |
最近18个月 | 1,844,960 | 342,060 | 1,502,900 |
最近36个月 | 1,844,960 | 462,060 | 1,382,900 |
Inhibrx Inc 内部交易
Inhibrx Inc 最新内部交易
Viking Global Investors Lp | 10% Owner | 2023-08-28 | 买入 | 511,627 | 7,150,826 |
$19.35
|
+80.36%
|
Mark Lappe | CEO | 2023-02-28 | 卖出 | 60 | 3,045,654 |
$25.02
|
+39.49%
|
Brendan P. Eckelman | Chief Scientific Officer | 2023-02-02 | 卖出 | 40,000 | 2,235,553 |
$24.93
|
+39.99%
|
Mark Lappe | CEO | 2023-01-24 | 卖出 | 26,000 | 3,045,714 |
$25.42
|
+37.29%
|
Jon Faiz Kayyem | 董事 | 2023-01-23 | 卖出 | 9,500 | 3,274,301 |
$25.26
|
+38.16%
|
Brendan P. Eckelman | Chief Scientific Officer | 2023-01-04 | 卖出 | 40,000 | 2,275,553 |
$23.71
|
+47.20%
|
Jon Faiz Kayyem | 董事 | 2022-12-21 | 卖出 | 9,500 | 3,283,801 |
$27.02
|
+29.16%
|
Mark Lappe | CEO | 2022-12-19 | 卖出 | 26,000 | 3,071,714 |
$25.56
|
+36.54%
|
Brendan P. Eckelman | Chief Scientific Officer | 2022-12-06 | 卖出 | 40,000 | 2,315,553 |
$27.22
|
+28.21%
|
Jon Faiz Kayyem | 董事 | 2022-11-21 | 卖出 | 9,500 | 3,293,301 |
$29.89
|
+16.76%
|